Fund comparison · from official SEC filings

BIPIX vs XBI: how much do they overlap?

BIOTECHNOLOGY ULTRASECTOR PROFUND and State Street(R) SPDR(R) S&P(R) Biotech ETF
Holdings overlap
70%
of assets, by weight
Shared positions
144
of 147 / 155 holdings
BIPIX expense ratio
1.52%
net, per year
XBI expense ratio
0.35%
net, per year
BIPIX and XBI are largely redundant — holding both means most of your money tracks the same underlying companies.
Shared holdings
Company
BIPIX
XBI
1
1JKAPELLIS PHARMACEUTICALS INC
1.32%
1.70%
A
ALKSALKERMES PLC
0.98%
1.34%
M
MDGLMADRIGAL PHARMACEUTICALS INC
0.97%
1.28%
T
TGTXTG THERAPEUTICS INC
0.97%
1.25%
I
INSMINSMED INC
0.79%
1.24%
S
SRRKSCHOLAR ROCK HOLDING CORP
0.87%
1.20%
A
APGEAPOGEE THERAPEUTICS INC
0.89%
1.19%
R
RVMDREVOLUTION MEDICINES INC
1.17%
1.03%
P
PTGXPROTAGONIST THERAPEUTICS INC
0.83%
1.15%
S
SMMTSUMMIT THERAPEUTICS INC
0.99%
1.15%
U
UTHRUNITED THERAPEUTICS CORP
0.84%
1.15%
T
TVTXTRAVERE THERAPEUTICS INC
1.15%
1.06%
P
PRAXPRAXIS PRECISION MEDICINES I
0.86%
1.14%
A
ARWRARROWHEAD PHARMACEUTICALS IN
1.02%
1.14%
C
COGTCOGENT BIOSCIENCES INC
0.80%
1.13%
B
BBIOBRIDGEBIO PHARMA INC
0.80%
1.10%
P
PTCTPTC THERAPEUTICS INC
0.80%
1.09%
C
CYTKCYTOKINETICS INC
0.81%
1.09%
A
ALNYALNYLAM PHARMACEUTICALS INC
0.78%
1.09%
E
EXELEXELIXIS INC
0.86%
1.08%
?
Nuvalent Inc
0.81%
1.08%
K
KYMRKYMERA THERAPEUTICS INC
0.80%
1.08%
C
CGONCG ONCOLOGY INC
0.81%
1.08%
N
NTRANATERA INC
0.84%
1.07%
N
NBIXNEUROCRINE BIOSCIENCES INC
0.82%
1.07%
Only in BIPIX
?
N/A
27.27%
A
AGPXXINVESCO GVT & AGNCY-INST
2.01%
T
TRAXFIRST TRACKS BIOTHERAPEUTICS
0.11%
Only in XBI
G
GVMXXSTATE ST INST US GOV MM-PREM
7.47%
A
AM6AMICUS THERAPEUTICS INC
1.06%
A
ACLXARCELLX INC
1.06%
?
Day One Biopharmaceuticals Inc
0.30%
?
CONTRA METSERA INC
0.09%
?
CONTRA AKERO THERAPEUT
0.02%
?
CONTRA INHIBRX INC
0.01%
?
CONTRA MIRATI THERAPEU
0.01%
?
CONTRA VERVE THERAPEUT
0.01%
?
CONTRA BLUEPRINT MEDIC
0.00%
O
OABIOMNIAB INC
0.00%
Hold BIPIX and XBI together? See your combined true holdings, overlap, and blended fees — free, no signup.
Unwrap your portfolio →
Data source: official SEC Form N-PORT filings from each fund. Fund holdings are disclosed quarterly and may reflect a 60-day reporting delay.
Informational and educational only — not investment advice.